SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Injective taken over by the community.

Nonja

$NONJA.X is trending as community members highlight its strong community, unique art, and potential for amplified gains as a meme coin on the Injective chain ($INJ.X). The community is closely watching for potential catalysts, including a possible staked $INJ.X ETF, which could further boost $NONJA.X.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as a Bitcoin-native meme coin, emphasizing its fair launch and strong community, known as the #DOGArmy. Community members highlight its integration with the Bitcoin network, and some suggest it could outperform other meme coins. There is also discussion around potential exchange listings and price targets.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors anticipate the results from the global Phase III HARMONi clinical trial for Ivonescimab, which will be presented at the World Conference on Lung Cancer. Community discussions revolve around the potential for positive Overall Survival (OS) data, particularly for Western patients, and speculation about a possible Biologics License Application (BLA) filing. Some traders are also discussing the possibility of a large licensing deal with AstraZeneca, which could be a catalyst for significant upside.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to a potential catalyst related to the company's land assets and a planned liquidation, sparking speculation of a significant value unlock. The stock's low float is fueling discussions about potential for a rapid price surge, with some traders eyeing a run back to previous highs. Community members are closely monitoring volume and key breakout levels, anticipating a possible squeeze.

Numeraire

Numeraire is trending as traders discuss a potential investment from a major US bank, which the community believes could significantly increase the token's value. Community members are closely watching key price levels, anticipating a breakout and further upward movement. The coin's AI narrative and low circulating supply contribute to the bullish sentiment.

WorldFinancial

WorldFinancial (WLFI.X) is trending amid community discussions about its potential as a top DeFi platform and speculation around large buy orders. The coin's strong chart patterns and technical validation are being actively discussed, with some anticipating a rise. Broader market interest is fueled by its association with real-world asset tokenization.

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

DCTH is trending due to positive sentiment around its growth potential and recent updates to treatment guidelines, with the community actively discussing its expansion into colorectal and breast cancer treatments. In addition, the CHOPIN study data expected in October is a hot topic. Discussions also include short interest, institutional ownership, and speculation about potential acquisition.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as investors discuss its technical patterns, including Elliott Wave setups and cup formations, with some eyeing a potential breakout. The community is also analyzing Netflix's revenue and subscriber growth, with management projecting a trillion-dollar valuation by 2030 through expansion into gaming, live sports, and branded attractions. Bullish sentiment is further fueled by discussions around a possible stock split.

Volatility Shares Trust - Volatility Shares Trust XRP ETF

XRP ETF

XRPI is trending as traders discuss the potential approval of XRP ETFs and increased adoption of Ripple's technology. Community members are analyzing price charts, anticipating a surge, and debating the best strategies for long-term investment in XRP-related assets. Talk centers around XRP's role in global payments and its potential impact on the banking industry.

Direxion Shares ETF Trust - Direxion Daily Gold Miners Index Bull 2X Shares

Direxion Daily Gold Miners Index Bull 2X Shares

NUGT is trending as traders discuss gold's potential breakout and miners possibly outperforming the market. Community members are weighing long and short positions, watching for key levels and reacting to news related to gold prices. Bullish sentiment seems to be building due to factors like geopolitical uncertainty, potential rate cuts, and perceived undervaluation of gold miners.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pfizer's 6.9% Yield & Bullish Signal: A Prime Buying Opportunity? 

Pfizer's strong Q2 results, high dividend yield, and bullish chart fuel optimism despite patent losses and rising competition. 

Pfizer Inc. (PFE) defended its COVID-19 vaccine transparency efforts on Wednesday, following President Donald Trump's call for the pharmaceutical industry to disclose the results of COVID-19 drugs to the public.Pfizer also lauded President Trump for initiating “Operation Warp Speed” and helping the country save over $1 trillion in healthcare costs due to a reduction in serious illnesses and subsequent hospitalizations. “Such an accomplishment would typically be worthy of the Nobel Peace Prize, given its significant impact,” the company said in a statement.Pfizer’s response comes two days after President Trump said he wanted answers from pharma companies on the success of their COVID-19 drugs. “It is very important that the Drug Companies justify the success of their various Covid Drugs. Many people think they are a miracle that saved Millions of lives. Others disagree! With CDC being ripped apart over this question, I want the answer, and I want it NOW,” the President&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://truthsocial.com/@realDonaldTrump/posts/115128985245605660">said</a> in a post on Truth Social.<figure class="image"><img style="aspect-ratio:730/768;" src="https://news.stocktwits-cdn.com/Trump_post_jpg_2d66b44311.webp" alt="President Donald Trump's post on Truth Social" width="730" height="768"><figcaption>President Donald Trump's post on Truth Social | @realDonaldTrump/Truth Social</figcaption></figure><a href="https://stocktwits.com/symbol/PFE">Pfizer’s shares</a> fell 0.34% in Wednesday’s opening trade. Retail sentiment on Stocktwits around the company trended in the ‘bearish’ territory.Trump added that while the information shown to him by Pfizer and other pharma companies was “extraordinary,” he wants them to relay this to the Centers for Disease Control and Prevention (CDC) and the public. Pfizer welcomed Trump’s call for transparency, while adding that data on its COVID-19 vaccine have appeared in over 600 peer-reviewed publications.<a href="https://stocktwits.com/symbol/PFE">PFE stock</a> is down 6% year-to-date and 12% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/fed-waller-backs-interest-rate-cuts-ahead-of-fomc-meet/chwcGWgRd8s">Fed’s Waller Says Central Bank ‘Needs To Start Cutting Rates This Month’, Warns Labor Market Could Turn Bad Fast: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, Ruth Jones, Immunization Nurse, holds a Pfizer-BioNTech COVID-19 vaccine (brand name: Comirnaty) at Borinquen Health Care Center on May 29, 2025 in Miami, Florida

Pfizer Defends Transparency On COVID-19 Vaccine Data, Says Trump’s ‘Operation Warp Speed’ Effort Deserves Nobel Peace Prize

Pfizer lauded “Operation Warp Speed” for helping the country save over $1 trillion in healthcare costs due to a reduction in serious illnesses and subsequent hospitalizations.

Equity

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.

Is DefenCath Sufficient to Support CorMedix's Long-Term Growth Path?

CRMD's DefenCath, its only revenue source, posts $78.8M in sales in H1 2025, with exclusivity through 2033 fueling growth potential.

Pfizer's Golden Cross Signals Strength: How to Play the Stock

Pfizer trades above key SMAs with a golden cross, while new drugs and cost cuts drive growth despite looming headwinds.

Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day

Boyd Gaming surges on strong earnings and growth plans, while Shoe Carnival struggles with sliding sales and weaker momentum.

U.S. stocks advanced for a third straight session on Thursday despite artificial intelligence (AI) chip giant Nvidia Corp. (NVDA) slipping after its quarterly report. The broader S&amp;P 500 Index hit a new record, while the 30-stock Dow Jones Industrial blue-chip average also closed at a record high, although it failed to breach its intraday record.Amid the market’s record run, the following stocks saw increased activity in Thursday’s after-hours trading.Marvell Technology, Inc. (MRVL)After-hours move: -11.28%Trading volume: 10.04 million<a href="https://stocktwits.com/symbol/MRVL">Marvell stock</a> slumped in Thursday’s extended session after the company reported a smaller-than-expected increase in data center revenue for the second quarter and also issued a lackluster forecast for the current quarter.&nbsp;On Stocktwits, retail sentiment toward the stock improved to ‘extremely bullish’ (94/100) by late Thursday, from ‘neutral’ a day ago, and the message volume also picked up steam to ‘extremely high levels.<figure class="image"><img style="aspect-ratio:1150/112;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_29_at_12_42_43_AM_png_41de4b6d97.webp" alt="Screenshot 2025-08-29 at 12.42.43 AM.png" width="1150" height="112"><figcaption>MRVL sentiment and message volume as of 12:45 a.m. ET, Aug. 29 | source: Stocktwits</figcaption></figure>Marvell stock has fallen about 30% year-to-date (YTD).Nvidia Corp. (NVDA)After-hours move: -0.32%Trading volume: 9.7 millionNvidia remained on investors’ radar after the slowdown in data center sales, amid China headwinds, led to a modest pullback in the stock. Most Wall Street analysts, who had bumped up their price targets in a preemptive move ahead of the earnings report, announced another round of increases, convinced of the near-term outlook.&nbsp;Retail mood toward Nvidia’s stock remained ‘extremely bullish’ (86/100) and the message volume was also ‘extremely high.’<figure class="image"><img style="aspect-ratio:1144/108;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_29_at_12_44_19_AM_png_3b0054bc91.webp" alt="Screenshot 2025-08-29 at 12.44.19 AM.png" width="1144" height="108"><figcaption>NVDA sentiment and message volume as of 12:45 a.m. ET, Aug. 29 | source: Stocktwits</figcaption></figure>The stock has risen over 34% this year.Bank of America Corp. (BAC)After-hours move: -0.02%Trading volume: 5.94 millionShares of Bank of America reached a new 52-week high, climbing to their highest level since late 2007, as investor sentiment improves. That said, the stock underperformed the broader market on Thursday, aligning with its Wall Street counterparts.With interest rates set to drop as the Federal Reserve is widely expected to cut rates, financial companies could come under pressure due to a potential squeeze on&nbsp;their net interest margin.&nbsp;On Stocktwits, sentiment toward&nbsp;<a href="https://stocktwits.com/symbol/BAC">Bank of America stock</a> and the message volume remained ‘bullish’ (61/100) and ‘high.’<figure class="image"><img style="aspect-ratio:1140/110;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_29_at_12_45_43_AM_png_6c97bb5af0.webp" alt="Screenshot 2025-08-29 at 12.45.43 AM.png" width="1140" height="110"><figcaption>BAC sentiment and message volume as of 12:45 a.m. ET, Aug. 29 | source: Stocktwits</figcaption></figure>Thus far this year, the stock has gained over 16%.Alphabet, Inc. (GOOGL) (GOOG)After-hours move: -0.04%Trading volume: 5.22 million<a href="https://stocktwits.com/symbol/GOOGL">Alphabet stock</a> rallied over 2% in Thursday’s regular session, a day after a report said the company had, over the past year, cut one-third of management positions overseeing smaller teams as part of a restructuring move.The company recently rolled out a new image editing AI model, named Nano Banana, in its Gemini App. Late Thursday, Singapore-based Pollo AI announced the launch of Nano Banana, also known as Gemini 2.5 Flash Image, on its platform.&nbsp;The Sundar Pichai-led company said in a blog post on Wednesday that it plans to invest an additional $9 billion in Virginia through 2026 in cloud and AI infrastructure.Alphabet stock, which has risen 12.7% YTD, elicited ‘neutral’ sentiment (50/100) from Stocktwits users, deteriorating from the ‘bullish’ mood seen a day ago. The message volume on the stream was at ‘low’ levels.<figure class="image"><img style="aspect-ratio:1138/112;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_29_at_12_46_54_AM_png_4f6d9c323f.webp" alt="Screenshot 2025-08-29 at 12.46.54 AM.png" width="1138" height="112"><figcaption>GOOGL sentiment and message volume as of 12:45 a.m. ET, Aug. 29 | source: Stocktwits</figcaption></figure>Pfizer, Inc. (PFE)After-hours move: +0.20%Trading volume: 4.88 million<a href="https://stocktwits.com/symbol/PFE">Pfizer stock</a> fell nearly 2% on Thursday after its updated COVID-19 vaccine, manufactured in partnership with Germany’s BioNTech (BNTX), received FDA approval, although with restrictions. It can be used only in people aged 65 years or older, and people aged 5 to 64 years who have underlying conditions that place them at risk of developing COVID.Sentiment toward the stock remained at ‘bearish’ (37/100) and the message volume was at ‘low’ levels.<figure class="image"><img style="aspect-ratio:1146/98;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_29_at_12_48_10_AM_png_a62a1af896.webp" alt="Screenshot 2025-08-29 at 12.48.10 AM.png" width="1146" height="98"><figcaption>PFE sentiment and message volume as of 12:45 a.m. ET, Aug. 29 | source: Stocktwits</figcaption></figure>Pfizer stock is down over 2% YTD.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp; <a href="https://stocktwits.com/news-articles/markets/equity/dell-marks-1.7-trillion-in-lifetime-revenue-q2-beat-on-ai-demand-stock-dips/chtTTFKRdZX">Dell Marks $1.7 Trillion In Lifetime Revenue After Q2 Beat On 'Exceptional' AI Demand — But Stock Dips Hard On EPS Outlook, Margin Concerns</a>

Traders work on the floor of the New York Stock Exchange (NYSE) on May 19, 2025 in New York City. Stocks were down sharply as traders react to Moody's downgrading the United States' credit rating. 

Marvell, Nvidia, Bank of America, Alphabet, Pfizer: What Sparked Heavy After-Hours Trading In These 5 Stocks?

Skepticism about the AI revolution gaining momentum has gained ground after Nvidia and Marvell reported soft data center sales. 

FDA Approves Updated COVID-19 Vaccines but With Restrictions

FDA clears updated COVID-19 vaccines from Pfizer, Moderna and Novavax but limits access to older adults and high-risk groups.

MRK, Daiichi Begin Phase III Breast Cancer Study With ADC Candidate

Merck and Daiichi Sankyo begin dosing in the phase III HERTHENA-Breast04 study on patritumab deruxtecan in certain breast cancer patients.

Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?

ALNY's Amvuttra revenues surge with 89% sales growth in H1 and a key label expansion, but faces tough competition in the ATTR-CM market.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

PFE
Pfizer Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PFE News

PFE Pfizer Inc